Abstract
Objectives
Cardiac implantable electronic device (CIED)–induced metal artefacts possibly significantly diminish the diagnostic value of magnetic resonance imaging (MRI), particularly cardiac MR (CMR). Right-sided generator implantation, wideband late-gadolinium enhancement (LGE) technique and raising the ipsilateral arm to the generator during CMR scanning may reduce the CIED-induced image artefacts. We assessed the impact of generator location and the arm-raised imaging position on the CIED-induced artefacts in CMR.
Methods
We included all clinically indicated CMRs performed on patients with normal cardiac anatomy and a permanent CIED with endocardial pacing leads between November 2011 and October 2019 in our institution (n = 171). We analysed cine and LGE sequences using the American Heart Association 17-segment model for the presence of artefacts.
Results
Right-sided generator implantation and arm-raised imaging associated with a significantly increased number of artefact-free segments. In patients with a right-sided pacemaker, the median percentage of artefact-free segments in short-axis balanced steady-state free precession LGE was 93.8% (IQR 9.4%, n = 53) compared with 78.1% (IQR 20.3%, n = 58) for left-sided pacemaker (p < 0.001). In patients with a left-sided implantable cardioverter-defibrillator, the median percentage of artefact-free segments reached 87.5% (IQR 6.3%, n = 9) using arm-raised imaging, which fell to 62.5% (IQR 34.4%, n = 9) using arm-down imaging in spoiled gradient echo short-axis cine (p = 0.02).
Conclusions
Arm-raised imaging represents a straightforward method to reduce CMR artefacts in patients with left-sided generators and can be used alongside other image quality improvement methods. Right-sided generator implantation could be considered in CIED patients requiring subsequent CMR imaging to ensure sufficient image quality.
Key Points
• Cardiac implantable electronic device (CIED)–induced metal artefacts may significantly diminish the diagnostic value of an MRI, particularly in cardiac MRIs.
• Raising the ipsilateral arm relative to the CIED generator is a cost-free, straightforward method to significantly reduce CIED-induced artefacts on cardiac MRIs in patients with a left-sided generator.
• Right-sided generator implantation reduces artefacts compared with left-sided implantation and could be considered in CIED patients requiring subsequent cardiac MRIs to ensure adequate image quality in the future.
Supplementary Information
The online version contains supplementary material available at 10.1007/s00330-022-09059-w.
Keywords: Magnetic resonance imaging; Pacemaker, Artificial; Defibrillators, Implantable; Artefacts; Electrodes, Implanted
Introduction
Cardiac magnetic resonance (CMR) imaging is often the preferred imaging method for the advanced evaluation of the heart, allowing for the non-invasive assessment of cardiac function, structure, myocardial scars and hemodynamics [1]. The clinical impact of CMR imaging is significant also in CIED patients [2–4]. The current European Society of Cardiology Guidelines on cardiac pacing approve magnetic resonance imaging (MRI) in patients with a cardiac implantable electronic device (CIED), such as pacemakers (PMs), implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy (CRT) devices [5]. However, CIEDs induce local magnetic field inhomogeneities due to the metallic materials used in the CIED generators and pacing leads resulting in susceptibility-based artefacts on MRI [6, 7]. These artefacts appear as signal loss areas and geometric distortions in the images. Moreover, when using balanced steady-state free precession (bSSFP) sequences for cine or late-gadolinium enhancement (LGE) imaging, any ferromagnetic material in or near the field of view increases the presence of banding artefacts in the images. These CIED-induced image artefacts may significantly degrade the image quality (IQ) and diagnostic value of MRIs, especially in the areas close to the generator, such as the heart [8–11].
Several methods for reducing CIED-related artefacts have been proposed in recent studies, such as right-sided generator implantation and wideband LGE imaging [8, 12, 13]. More generally, metal artefacts can be reduced by using wideband bSSFP pulse sequences, a frequency-scout method prior to the bSSFP cine and LGE imaging, and spoiled gradient echo (SPGR) sequences instead of bSSFP [14, 15].
In addition, elevating the ipsilateral arm relative to the CIED generator during MRI has been described as a part of CIED patient MRI scanning protocols [16]. Raising the arm on the side of the generator increases the distance between the heart and the generator (Fig. 1). This method has been used to decrease CIED-induced artefacts overlaying the myocardium [6, 16, 17]. However, the effect of arm-raised imaging on CMR IQ remains unknown.
In this retrospective study, we aimed to report on CMR IQ and safety in patients with CIED and to assess the impact of arm-raised imaging and generator implantation site on the CIED-induced artefacts.
Materials and methods
This retrospective study of MRIs from patients with CIED was approved by the Helsinki University Hospital Medical Imaging Center review board. No informed consent was required. The data cannot be made available to other researchers for the purposes of reproducing the results, given the restrictions imposed by the research permissions. Individual-level data cannot be shared openly.
Study population
We evaluated all CMRs performed on adult patients with CIED at Helsinki University Hospital between November 2011 and October 2019 (n = 260). All CMRs were clinically indicated, except for one CMR, which was scanned as a part of a clinical study. Patients with congenital heart disease (n = 60), epicardial pacing leads (n = 2), subcutaneous ICDs (n = 2), temporary permanent pacemaker systems (n = 24) and for whom CMR image data were absent (n = 1) were excluded. All CMRs in patients with a permanent CIED and endocardial pacing leads and available CMR image data were included in this study (n = 171).
Data collected from the electronic medical records
The following information was collected from patient electronic medical records (EMRs): patient date of birth, sex, CIED generator model, date of the CIED implantation, site of the CIED generator implantation, date of the CMR scan and information on the pacing device interrogation prior to and after the CMR scan. EMRs were searched specifically for any CIED-related safety hazards or adverse outcomes during or after the CMR scan, such as generator failure, power-on reset, clinically relevant changes in the pacing threshold or sensing that required system revision or programming changes, unexpected battery depletion and pacing inhibition and patient-reported events, such as discomfort, pain, a warm sensation at the location of the device and palpitations.
CMR protocol
All CMR examinations were performed using a 1.5T system (Siemens MAGNETOM Avanto, which in summer 2013 was upgraded to a Siemens MAGNETOM Avantofit (both from Siemens Healthcare). The CMR scans were performed following our institutional MRI in a CIED patient safety protocol presented in detail earlier [18, 19]. The CMR examinations were performed with variable protocols. Considering the CMR imaging indication, the appropriate scanning protocol was selected case by case. Typically, a CMR scan consisted of localiser imaging, cines, a T2-weighted turbo spin echo, modified Look-Locker inversion recovery T1 mapping, T2 mapping, rest perfusion and late-gadolinium-enhanced (LGE) imaging sequences. For cine imaging, bSSFP (TrueFISP) or SPGR (FLASH) sequences were used. According to our institutional protocols, bSSFP sequences are primarily used for cine and LGE image acquisition. However, SPGR sequences are used when large, CIED-induced artefacts are present over the myocardium already in the localiser images or in the first scanned bSSFP cine images. The used contrast agent was gadoteric acid—gadoterate meglumine (Dotarem® 279.3 mg/ml, Guerbet). The typical dose of contrast agent administration was 0.4 ml/kg.
CMR IQ assessment
Selected sequences of the included CMR examinations were evaluated for the presence of artefacts; cine and LGE, both the conventional inversion recovery and phase-sensitive inversion recovery (PSIR) images acquired using bSSFP or SPGR techniques, were evaluated along three planes: short axis (SAX), four-chamber (4ch) and two-chamber (2ch) (Fig. 2). We used the American Heart Association (AHA) 17-segment model to detect regional differences in artefacts [20]. In the cine, conventional LGE and PSIR images, the left ventricular (LV) segments were evaluated for the presence of CIED-related artefacts (yes/no) through consensus among two radiologists (one experienced radiologist, specialised in CMR with over 10 years of experience, and one radiology resident also familiar with CMR examinations). The area (cm2) of the susceptibility-related artefact induced by the right ventricular (RV) pacing lead tip was measured in SAX sequences. In the same manner, the LV coronary sinus lead-induced artefact area (cm2) was measured in CRT patients. In addition, the largest diameter (cm) of the signal-void artefact caused by the CIED generator was measured from the bSSFP localiser images. The distance from the generator to the heart was measured using the coronal localiser images of the CMR (the shortest distance from the middle of the signal-void area artefact induced by the CIED generator to the border of the heart, cm). The longest distance from the middle of the signal-void artefact area to any banding artefact induced by the CIED generator was also measured using the coronal bSSFP localiser images. Variability in selected measured artefact variables (generator-induced signal-void artefact diameter, distance from the generator to the heart, distance of the banding artefact and RV lead tip–induced artefact area in SAX bSSFP and SPGR sequences) between two expert observers was evaluated in a small sample (n = 25 CMR examinations).
Statistical analysis
Numerical results are given as mean ± standard deviation (SD) or median (interquartile range [IQR]), as appropriate. Variable comparisons between several groups were calculated using the Kruskal-Wallis test applying the post hoc Dunn test with Bonferroni’s adjustment. The Mann-Whitney U-test was used for pairwise comparisons. p values < 0.05 were considered statistically significant. The interobserver variability was assessed using an intraclass correlation coefficient (ICC) with a 95% confidence interval (CI). Absolute agreement using the two-way mixed model was calculated. ICC < 0.50 was considered poor. Data were analysed using SPSS (IBM Corp. Released 2013. IBM SPSS Statistics for Windows, Version 25.0).
Results
Baseline characteristics
In total, 171 CMR examinations from 167 patients with CIED (85 females, 50.9%) were included in this study. The patients’ mean age at the time of MRI was 58.8 ± 13.2 years (range 22–84 years). The implantation of the CIED generator was performed on average 2.6 ± 2.7 years (range 0–12.5 years) prior to the CMR imaging. All generators were implanted in the year 2005 or later. The time of implantation was missing in three cases. Four patients underwent two CMR scans. The majority (78.9%) of the CMR examinations were performed on patients with a PM, while 12.9% of patients had an ICD and 8.2% had a CRT device, respectively (Table 1). Most generators of the CIEDs (60.2%, n = 103) were classified as MR unsafe models according to the MR Task group of the American Society for Testing and Materials (ASTM) International [21, 22]. The data on CIED MR compatibility was missing in two cases (1.2%). Seven patients underwent a CMR with an abandoned endocardial pacing lead, and additionally, one patient had an abandoned PM system in addition to the functioning CIED system.
Table 1.
bSSFP balanced steady-state free precession, CIED cardiac implantable electronic device, CRT cardiac resynchronization therapy device, ICD implantable cardioverter-defibrillator, IQR interquartile range, LGE late-gadolinium enhancement, PM pacemaker, PSIR phase-sensitive inversion recovery, SAX short axis, SPGR spoiled gradient echo, 2ch two-chamber, 4ch four-chamber
CMR imaging safety in patients with CIED
Adverse events were detected in three CMR examinations (3/171, 1.8%). These consisted of an unintended change to the CIED pacing mode, an ICD beeper malfunction and a reversible elevation of the pacing threshold. CMRs in patients with abandoned leads and abandoned PM systems were performed without detectable adverse events.
The CMR was prematurely interrupted in two patients. In a patient with a CRT-D, the CMR was interrupted after a few SPGR cine sequences due to the major CIED-induced artefacts and insufficient IQ. One patient with a PM had a large amount of pleural fluid leading to an ECG gating problem, and the CMR was aborted.
In one PM-dependent patient, the PM (generator model Medtronic Kappa KSR 401) was programmed to asynchronous pacing mode (DOO) before the MRI examination. However, during the MRI, the PM reached the elective replacement indicator (ERI) mode due to temporarily programmed high output voltage, which led to an inhibited pacing mode (VVI). After the MRI, the PM was reprogrammed, and its function reverted to normal. In one patient, the audible alarm failure of an ICD was noted following the MRI (ICD generator model: Boston Scientific Autogen EL VR). The beeper malfunction did not affect the function of the ICD. A reversible elevation of the pacing threshold was detected in another patient with an ICD (Medtronic Evera MRI DVMC3D4 generator and 6947M Sprint Quattro Secure 62 cm lead). In this patient, the pacing threshold 1.5 years before the MRI was 0.75V/0.4ms, while immediately following the MRI, the pacing threshold was elevated to 2.25V/0.4 ms or 1.5V/0.8 ms, which required reprogramming of the device (the pulse width was increased to 0.8 ms). The pacing threshold values immediately before the MRI were missing in the EMR. Ten months after the MRI, the pacing threshold was decreased to 1.625V/0.4 ms, and 2.5 years later, the pacing threshold was 1.25V/0.4 ms.
CIED-induced artefacts on CMR
The analysis of CIED-induced CMR artefacts per segment revealed that patients with ICD or CRTs had more artefacts than patients with PM in almost all evaluated sequences (Table 1). Description of artefact-free segments in CRT-D and CRT-P groups separately is provided in Supplementary Table 1. Typical appearances of the CIED-induced artefacts on CMR are presented in Fig. 3. The diameter of the susceptibility artefact (i.e. the signal loss area) caused by the CIED generator was substantially larger with ICDs than with PMs (Table 2). However, we detected no significant difference in the artefact area induced by the RV lead tip between the CMRs with PMs and ICDs (Table 3). The LV coronary sinus lead-induced artefact was measured in CRT patients (n = 14). LV lead-induced artefact could not be measured in two CRT patients: no image data in SAX planes were available in one patient. In another patient, the LV lead-induced artefact was not distinguishable from the generator-induced artefacts. The medians of measured LV lead-induced artefact areas in bSSFP sequences were as follows: cine SAX 0.34 (0.31–0.51) cm2 (n = 7), LGE SAX 0.38 cm2 (n = 3), PSIR SAX 0.37 (0.28–0.47) cm2 (n = 5). Similarly, the medians in SPGR sequences were as follows: cine SAX 0.38 (0.31–0.67) cm2 (n = 7), LGE SAX 0.32 (0.27–0.65) cm2 (n = 5), PSIR SAX 0.37 (0.31–0.51) cm2 (n = 5); the distribution of CIED-induced artefacts in patients with a left-sided PM or ICD in selected sequences is presented in Fig. 4. The anterior wall and septal segments of the LV were the most affected by artefacts. The interobserver variability in the analysed variables ranged from excellent to poor. The best correlations were obtained in the generator artefact diameter, ICC 0.84 (CI 0.84–0.85), and the generator distance from the heart, ICC 0.87 (CI 0.87–0.88), while the RV lead artefact area in bSSFP PSIR, SPGR PSIR and LGE images had a poor agreement (ICC < 0.50) between the observers (Suppl. Table 2).
Table 2.
n (%) | PM | 135 (78.9%) | ICD | 22 (12.9%) | CRT-D | 9 (5.3%) | CRT-P | 5 (2.9%) | Total n = 171 | |
---|---|---|---|---|---|---|---|---|---|---|
n | Median (IQR) | n | Median (IQR) | n | Median (IQR) | n | Median (IQR) | p valuea | p values of post hoc comparisons | |
Susceptibility signal-void artefact diameter measured from coronal localiser (bSSFP), cm | 126 | 8.9 (7.9–9.8) | 19 | 13.6 (12.6–14.5) | 7 | 14.1 (13.0–14.8) | 5 | 9.5 (9.0–9.7) | < 0.001 | < 0.001 (PM–ICD) < 0.001 (PM–CRT-D) 0.045 (CRT-P–ICD) |
Banding artefact distance measured from coronal localiser (bSSFP), cm | 126 | 10.4 (8.9–12.3) | 19 | 20.6 (18.2–21.7) | 7 | 18.8 (18.2–24.6) | 5 | 11.8 (10.3–13.3) | < 0.001 | < 0.001 (PM–ICD) < 0.001 (PM–CRT-D) |
Generator distance from the heart, measured from coronal localiser (bSSFP), cm | 126 | 10.3 (8.6–12.0) | 19 | 10.0 (8.5–11.9) | 7 | 10.5 (7.9–11.3) | 5 | 7.3 (6.5–10.7) | 0.341 |
aKruskal-Wallis test p value
bSSFP balanced steady-state free precession
CIED cardiac implantable electronic device
CRT-D cardiac resynchronization therapy defibrillator
CRT-P cardiac resynchronization therapy pacemaker
ICD implantable cardioverter-defibrillator
LGE late-gadolinium enhancement
IQR interquartile range
PM pacemaker
Table 3.
n (%) | PM | 135 (78.9%) | ICD | 22 (12.9%) | CRT-D | 9 (5.3%) | CRT-P | 5 (2.9%) | Total n = 171 |
---|---|---|---|---|---|---|---|---|---|
n | Median (IQR) | n | Median (IQR) | n | Median (IQR) | n | Median (IQR) | p value | |
bSSFP | |||||||||
Cine SAX RV lead artefact area (cm2) | 115 | 1.6 (1.2–2.1) | 5 | 1.9 (1.1–2.3) | 4 | 2.3 (2.1–3.5) | 4 | 1.6 (1.1–1.8) | 0.118 |
LGE SAX RV lead artefact area (cm2) | 110 | 1.6 (1.3–2.1) | 2 | 1.2 | 5 | 1.9 (1.9–2.2) | 1 | 1.1 | 0.160 |
PSIR SAX RV lead artefact area (cm2) | 113 | 1.6 (1.2–2.1) | 4 | 1.2 (0.9–1.7) | 6 | 1.9 (1.5–2.4) | 3 | 1.1 | 0.283 |
SPGR | |||||||||
Cine SAX RV lead artefact area (cm2) | 21 | 1.8 (1.3–2.4) | 18 | 1.4 (1.1–1.8) | 4 | 1.4 (1.3–2.3) | 3 | 2.0 | 0.083 |
LGE SAX RV lead artefact area (cm2) | 14 | 2.1 (1.3–2.7) | 16 | 1.8 (1.4–2.1) | 3 | 2.3 | 2 | 2.5 | 0.399 |
PSIR SAX RV lead artefact area (cm2) | 16 | 1.8 (1.3–2.5) | 16 | 1.8 (1.2–2.3) | 2 | 1.6 | 2 | 1.3 | 0.759 |
bSSFP balanced steady-state free precession
CIED cardiac implantable electronic device
CMR cardiac magnetic resonance imaging
CRT-D cardiac resynchronization therapy defibrillator
CRT-P cardiac resynchronization therapy pacemaker
ICD implantable cardioverter-defibrillator
LGE late-gadolinium enhancement
PM pacemaker
PSIR phase-sensitive inversion recovery
RV right ventricular
SAX short axis
SPGR spoiled gradient echo
Generator location and artefacts
The measured generator distance from the heart was significantly greater in patients with right-sided generators (11.2 ± 2.3 cm, CI 10.5–11.8 cm, n = 56) compared with patients with left-sided generators (9.6 ± 2.9 cm, CI 9.0–10.1 cm, n = 101); p < 0.001. Right-sided generator implantation significantly reduced the presence of artefacts in CMRs with a PM in all analysed bSSFP images (Table 4). However, the number of artefact-free segments in CMRs also remained higher in patients with left-sided PMs than in patients with left-sided ICDs in all evaluated SPGR LGE and PSIR planes (p ≤ 0.002). All ICDs and CRT-Ps were implanted on the left side.
Table 4.
bSSFP balanced steady-state free precession, CIED cardiac implantable electronic device, CMR cardiac magnetic resonance, CRT-D cardiac resynchronization therapy defibrillator, LGE late-gadolinium enhancement, PM pacemaker, PSIR phase-sensitive inversion recovery, RV right ventricular, SAX short axis, SPGR spoiled gradient echo, 2ch two-chamber, 4ch four-chamber
Arm-raised imaging and artefacts
In patients with a left-sided generator, the measured distance between the generator and the heart was significantly greater in patients with the arm-raised CMR scanning position (mean 11.0 ± 2.1 cm, CI 10.2–11.8, n = 28) than in patients with arm-down scanning position (mean 9.0 ± 3.0 cm, CI 8.3–9.7, n = 73); p < 0.001. In patients with a left-sided PM, the arm-raised CMR scanning position significantly increased the number of artefact-free segments on several bSSFP image stacks, thereby improving the IQ compared with arm-down scanning (Table 5). Furthermore, in patients with ICD, the arm-raised CMR scanning position improved the IQ significantly in the SPGR SAX cine and 2ch cine sequences (Table 5, Fig. 4).
Table 5.
bSSFP balanced steady-state free precession, CIED cardiac implantable electronic device, CMR cardiac magnetic resonance imaging, LGE late-gadolinium enhancement, PM pacemaker, PSIR phase-sensitive inversion recovery, SAX short axis, SPGR spoiled gradient echo, 2ch two-chamber, 4ch four-chamber
Discussion
We assessed the CMR IQ of patients with CIED. Our key finding was that the arm-raised imaging reduced CIED-induced artefacts, thus improving the IQ in patients with left-sided PM and ICD. Arm-raised CMR scanning is a simple and cost-free way of diminishing CIED-induced artefacts interfering with the myocardium and can be used alongside other artefact-reducing methods, such as wideband LGE image acquisition. We also noted that right-sided generator implantation improved the number of artefact-free LV segments on CMR in patients with PM. This observation was intuitive since the CIED generator remained outside the scanning field of view and the distance between the generator and the myocardium was greater than that achieved with left-sided generator implantation. The impact of CIED generator location on CMR IQ should be considered when CIED implantation is required for a patient with conditions requiring subsequent CMRs.
CMR safety in patients with CIED
Numerous large-scale studies have demonstrated the safety of thoracic MRIs in CIED patients [19, 23–26]. The low adverse event rate related to CMR scanning the CIED patients (1.8%) in our study is in line with the published literature. One patient in our patient cohort experienced a potentially catastrophic adverse event involving an unintended change to the CIED pacing mode during the MRI from the asynchronous pacing mode to the inhibited pacing mode in a PM-dependent patient with a Medtronic Kappa PM KSR 401generator. One study reported that older Medtronic Kappa PM models appear more likely to experience a power-on reset during MRI suggesting special attention may be needed with CIED patients undergoing MRI with these PM models [27]. Fortunately, the PM reverted to normal function after reprogramming, and inappropriate pacing inhibition leading to asystole due to electromagnetic interference did not occur in this reported case, which has already been described in our previous publication [19]. In addition, an ICD beeper malfunction was noticed after the MRI in one patient. In the current Boston Scientific ICD models, the beeper is located outside of the generator’s protective cover. Thus, the malfunctioning of the beeper represents an expected possible adverse event related to an MRI in these specific devices [28]. Importantly, the beeper malfunction does not affect the functioning of the ICD and, thus, does not carry a risk to patient safety. The third event was a transient elevation of the pacing threshold following a CMR detected in a patient with an ICD. This likely resulted from the lead heating up during MRI, causing oedema in the pacing lead tip area tissues. The CIED reprogramming was required. During follow-up, the pacing threshold reverted to the pre-MRI level. There was no need for CIED revision in this case. Similar transient and persistent elevations in the pacing threshold related to MRIs in patients with CIED have been reported in previous publications [2, 26, 29, 30].
The generators in our study population were considered modern (implanted in the year 2005 or later), but most of the generators (60.2%) were classified as MR unsafe models. The safety hazards of an MRI are considered more significant for patients with conventional CIEDs implanted before 2001, especially ICDs [31–33]. Notably, a recent large-scale study provides evidence that supports MR conditional labelling of all endocardial PM and defibrillator leads [33]. In clinical practice, the risks of MRI in CIED patients appear to be associated with factors related to the generator and not the leads [33]. Seven patients with abandoned endocardial pacing leads and one patient with an abandoned PM system were CMR scanned without adverse events. This finding is in keeping with the previous studies reporting low adverse event rates related to MRIs in patients with abandoned pacing leads [2, 19, 26, 34, 35].
CMR in patients with CIED: clinical significance and IQ
Based on previous studies, the clinical impact of CMR imaging on patients with CIED is high. CMR imaging data altered the diagnosis in 35% of the cases and confirmed the diagnosis in 54% of the cases in a study on the clinical impact and MRI safety in patients with MR unsafe CIEDs and abandoned leads [2]. Another study on the utility of CMR imaging in patients with ICD and electrical instability or worsening heart failure symptoms revealed that the CMR examination data changed the diagnosis in 40% of the cases, and management-changing information was gained in 21% of the cases [3]. Despite the potential benefits, CIED patients are underrepresented in MRI examinations [36, 37].
The CIED-induced artefacts may compromise the CMR IQ. Especially, ICDs and CRTs containing more ferromagnetic material than PMs result in more severe artefacts, often threatening the diagnostic value of CMR. An ICD may result in artefacts on CMR in > 50% of the LV segments [9, 10]. The anterior wall of the LV is the most affected area by the ICD-induced artefacts [38]. Our observations support these findings. In contrast, the RV pacing lead-induced artefacts have been shown to be minor and only mildly affecting the image interpretation [8, 39, 40]. Our study showed non-significant differences in the RV lead-induced artefact areas between subgroups of patients with different CIED types supporting that generator-related artefacts are the main factor for IQ differences. However, RV lead-induced artefact area measurements were non-reproducible in bSSFP PSIR, SPGR LGE and SPGR PSIR sequences indicating these results were non-reliable. To our best knowledge, previously, no data of LV coronary sinus lead-induced artefacts on CMR have been published. The measured LV lead-induced artefact areas seem minor in our study with a limited number of CRT patients. In general, the diameter of LV leads is smaller than that of RV leads [41]. Therefore, it seems reasonable that LV lead-induced artefacts do not significantly limit the interpretability of CMR images. Several factors affect the magnitude of the susceptibility artefacts, such as the magnetic susceptibility of the metal, the strength of the main magnetic field, the orientation of the ferromagnetic implant with respect to the main magnetic field, readout direction and the bandwidth [42, 43]. In addition, under a higher magnetic field strength, a greater field inhomogeneity effect of the implants results in larger artefacts. Thus, in general, 1.5T scanners provide fewer metal artefacts than higher field strength MRI scanners [43].
Methods to reduce CIED-related artefacts have been developed. Recent literature has well described that wideband bSSFP sequences, especially in terms of the wideband LGE acquisition, improve IQ in CIED patients [14, 25, 44–46]. Furthermore, using SPGR sequences instead of bSSFP for CMR scanning is beneficial in CIED patients but leads to a lower contrast between the myocardium and blood pool [8, 12, 47]. Moreover, a hyperintensity artefact on SPGR images may lead to difficulties in distinguishing between a myocardial scar and an artefact [7, 48, 49]. Right-sided generator implantation increases the distance between the heart and the generator, thereby reducing the CIED-induced artefacts compared with left-sided generator implantation [4]. Importantly, left-sided generator implantation is preferred with ICDs and CRT-Ds to ensure a low defibrillation threshold [50, 51]. Movement of the CIED generator away from the heart by raising the ipsilateral arm to the generator during CMR scanning has been previously described as an artefact reduction method [6, 16]. However, there is a lack of published literature concerning the actual effect of this method on CMR artefacts.
Our study revealed that arm-raised scanning genuinely improves CMR IQ in patients with a left-sided PM or ICD. This is an effective and straightforward method to decrease artefacts on CMR in CIED patients and may provide a significant clinical benefit. It should be noted, however, that CMR imaging requires being still for a reasonably long time, and arm-raised scanning may lead to patient discomfort and may not be suitable for all patients. In particular, patients with poor physical condition and patients with limited upper extremity function, e.g. due to joint conditions, may not be suitable candidates for arm-raised scanning position. We also noted that patients with a right-sided PM had significantly fewer artefacts on bSSFP sequences than patients with a left-sided PM, which is in line with previously published findings [4, 39]. Considering our findings and the existing literature, device-dependent modifications to the CMR scanning strategy likely improve IQ [47]. Taking the CIED type (PM/ICD/CRT) and the generator site (left/right) into account, the appropriate CMR scanning position (arm-down/arm-raised) and the CMR sequence type (i.e. bSSFP, SPGR and wideband bSSFP technique) could be modified.
Limitations
We must note several limitations to this study. CRT and ICD subgroups are limited in size in some of the tests. In the comparison of arm-raised and arm-down CMR scanning positions on SPGR IQ of ICD patients, the subgroups included less than 10 patients. Similarly, the CRT-D subgroups included 5 or fewer patients in the comparison of the IQ between left-sided and right-sided generators. The small sample sizes limit the large-scale generalizability of the results. Thus, studies with larger subgroups are needed to confirm the effectiveness of arm-raised scanning position as an artefact reduction method in CMR scanning of the CIED patients. However, to our knowledge, there are no previous publications on the effect of arm-raised imaging on CMR IQ in CIED patients, and we find our results promising. According to our safety protocol, only clinically significant changes in CIED parameter values are entered in the EMR. The data on the exact CIED parameter values were not retrospectively available. Thus, a statistical analysis of the parameter values before and after the CMR was not possible. In addition, we did not assess the CMR IQ of the right ventricle in CIED patients in our study. However, the findings of the right ventricle are of great interest, especially in selected cases, such as in the suspicion of arrhythmogenic right ventricular cardiomyopathy. Wideband LGE acquisition was not used in our institution. Furthermore, we did not assess the IQ in the T1 and T2 mapping sequences. The measurement of the artefact area and distances were mostly performed by one radiologist. However, interobserver variability was assessed in a small sample, which showed that measurements are potentially subjective and include inaccuracies. All CMRs were performed with a 1.5T scanner, and the results cannot be extrapolated to 3.0T scans.
Conclusions
CIED-related artefacts may significantly reduce the diagnostic value of CMR. Arm-raised imaging is a straightforward, costless method for reducing CIED-induced CMR artefacts in patients with left-sided generators, which can be used alongside other IQ improvement methods, such as wideband LGE. When clinically indicated, right-sided generator implantation should be considered in CIED patients known to require subsequent CMRs in order to ensure adequate IQ in the future.
Supplementary information
Abbreviations
- 2ch
Two-chamber
- 4ch
Four-chamber
- AHA
American Heart Association
- bSSFP
Balanced steady-state free precession
- CIED
Cardiac implantable electronic device
- CMR
Cardiac magnetic resonance
- CRT
Cardiac resynchronization therapy
- CRT-D
Cardiac resynchronization therapy defibrillator
- CRT-P
Cardiac resynchronization therapy pacemaker
- EMR
Electronic medical record
- ERI
Elective replacement indicator
- ICD
Implantable cardioverter-defibrillator
- IQ
Image quality
- LGE
Late-gadolinium enhancement
- LV
Left ventricular
- PM
Pacemaker
- PSIR
Phase-sensitive inversion recovery
- RV
Right ventricular
- SAX
Short axis
- SPGR
Spoiled gradient echo
Funding
Open Access funding provided by University of Helsinki including Helsinki University Central Hospital. This study has received funding from the HUS Medical Imaging Center research grant, Ida Montin Foundation research grant and Radiological Society of Finland research grant.
Declarations
Guarantor
The scientific guarantor of this publication is Touko Kaasalainen.
Conflict of interest
The authors of this manuscript declare relationships with the following companies: Abbott (Jarkko Karvonen), Medtronic (Jarkko Karvonen).
Statistics and Biometry
No complex statistical methods were necessary for this paper.
Informed consent
Written informed consent was not required for this study because research based purely on documentation or registered materials does not need to be reviewed by the regional ethics committees and informed written consent is not required for research based on purely documentation.
Ethical approval
Institutional Review Board approval was obtained.
Study subjects or cohorts overlap
Some study subjects or cohorts have been previously reported in Vuorinen AM, Pakarinen S, Jaakkola I, Holmstrom M, Kivisto S, Kaasalainen T (2019) Clinical experience of magnetic resonance imaging in patients with cardiac pacing devices: unrestricted patient population. Acta Radiol 60:1414-1421. One hundred twelve cardiac MRIs in were included in this previous publication and are also included in this study. However, our previous article concentrated on the general safety of MRI in patients with CIED and on the MRI safety protocol. This publication concentrates specifically on the CMR image quality and artefacts in CIED patients and adds valuable information in this field.
Methodology
• retrospective
• observational
• performed at one institution
Footnotes
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Leiner T, Bogaert J, Friedrich MG, et al. SCMR Position Paper (2020) on clinical indications for cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2020;22:76. doi: 10.1186/s12968-020-00682-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Gupta SK, Ya’Qoub L, Wimmer AP, Fisher S, Saeed IM. Safety and clinical impact of MRI in patients with non–MRI-conditional cardiac devices. Radiol Cardiothorac Imaging. 2020;2:e200086. doi: 10.1148/ryct.2020200086. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Lindemann F, Oebel S, Paetsch I, et al. Clinical utility of cardiovascular magnetic resonance imaging in patients with implantable cardioverter defibrillators presenting with electrical instability or worsening heart failure symptoms. J Cardiovasc Magn Reson. 2020;22:32. doi: 10.1186/s12968-020-00609-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Raphael CE, Vassiliou V, Alpendurada F, Prasad SK, Pennell DJ, Mohiaddin RH. Clinical value of cardiovascular magnetic resonance in patients with MR-conditional pacemakers. Eur Heart J Cardiovasc Imaging. 2016;17:1178–1185. doi: 10.1093/ehjci/jev305. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Glikson M, Nielsen JC, Kronborg MB, et al. 2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2021;42:3427–3520. doi: 10.1093/eurheartj/ehab699. [DOI] [PubMed] [Google Scholar]
- 6.Lee EM, Ibrahim E-SH, Dudek N et al (2021) Improving MR image quality in patients with metallic implants. Radiographics 41:E126–E137 [DOI] [PubMed]
- 7.Stojanovska J, Runge M, Mahani MG, et al. Cardiac MRI for patients with cardiac implantable electronic devices. AJR Am J Roentgenol. 2020;215:374–381. doi: 10.2214/AJR.19.21883. [DOI] [PubMed] [Google Scholar]
- 8.Kaasalainen T, Kivisto S, Holmstrom M, et al. Cardiac MRI in patients with cardiac pacemakers: practical methods for reducing susceptibility artifacts and optimizing image quality. Acta Radiol. 2016;57:178–187. doi: 10.1177/0284185115574873. [DOI] [PubMed] [Google Scholar]
- 9.Mesubi O, Ahmad G, Jeudy J, et al. Impact of ICD artifact burden on late gadolinium enhancement cardiac MR imaging in patients undergoing ventricular tachycardia ablation. Pacing Clin Electrophysiol. 2014;37:1274–1283. doi: 10.1111/pace.12405. [DOI] [PubMed] [Google Scholar]
- 10.Sasaki T, Hansford R, Zviman MM, et al. Quantitative assessment of artifacts on cardiac magnetic resonance imaging of patients with pacemakers and implantable cardioverter-defibrillators. Circ Cardiovasc Imaging. 2011;4:662–670. doi: 10.1161/CIRCIMAGING.111.965764. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Dandamudi S, Collins JD, Carr JC, et al. The safety of cardiac and thoracic magnetic resonance imaging in patients with cardiac implantable electronic devices. Acad Radiol. 2016;23:1498–1505. doi: 10.1016/j.acra.2016.08.016. [DOI] [PubMed] [Google Scholar]
- 12.Schwitter J, Gold MR, Al Fagih A, et al. Image quality of cardiac magnetic resonance imaging in patients with an implantable cardioverter defibrillator system designed for the magnetic resonance imaging environment. Circ Cardiovasc Imaging. 2016;9:e004025. doi: 10.1161/circimaging.115.004025. [DOI] [PubMed] [Google Scholar]
- 13.Ranjan R, Mcgann CJ, Jeong E-K, et al. Wideband late gadolinium enhanced magnetic resonance imaging for imaging myocardial scar without image artefacts induced by implantable cardioverter-defibrillator: a feasibility study at 3 T. Europace. 2015;17:483–488. doi: 10.1093/europace/euu263. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Nayak KS, Lee H-L, Hargreaves BA, Hu BS. Wideband SSFP: alternating repetition time balanced steady state free precession with increased band spacing. Magn Reson Med. 2007;58:931–938. doi: 10.1002/mrm.21296. [DOI] [PubMed] [Google Scholar]
- 15.Lee H-L, Shankaranarayanan A, Pohost GM, Nayak KS. Improved 3-Tesla cardiac cine imaging using wideband. Magn Reson Med. 2010;63:1716–1722. doi: 10.1002/mrm.22384. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Singh A, Kawaji K, Goyal N, et al. Feasibility of cardiac magnetic resonance wideband protocol in patients with implantable cardioverter defibrillators and its utility for defining scar. Am J Cardiol. 2019;123:1329–1335. doi: 10.1016/j.amjcard.2019.01.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Kebed KY, Carter SV, Flatley E, et al. Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study. Int J Cardiovasc Imaging. 2021;37:1361–1369. doi: 10.1007/s10554-020-02090-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Kaasalainen T, Pakarinen S, Kivisto S, et al. MRI with cardiac pacing devices - safety in clinical practice. Eur J Radiol. 2014;83:1387–1395. doi: 10.1016/j.ejrad.2014.04.022. [DOI] [PubMed] [Google Scholar]
- 19.Vuorinen A-M, Pakarinen S, Jaakkola I, Holmström M, Kivistö S, Kaasalainen T. Clinical experience of magnetic resonance imaging in patients with cardiac pacing devices: unrestricted patient population. Acta Radiol. 2019;60:1414–1421. doi: 10.1177/0284185119830288. [DOI] [PubMed] [Google Scholar]
- 20.Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. Circulation. 2002;105:539–542. doi: 10.1161/hc0402.102975. [DOI] [PubMed] [Google Scholar]
- 21.Kanal E, Barkovich AJ, Bell C, et al. ACR guidance document on MR safe practices: 2013. J Magn Reson Imaging. 2013;37:501–530. doi: 10.1002/jmri.24011. [DOI] [PubMed] [Google Scholar]
- 22.Cross NM, Hoff MN, Kanal KM. Avoiding MRI-related accidents: a practical approach to implementing MR safety. J Am Coll Radiol. 2018;15:1738–1744. doi: 10.1016/j.jacr.2018.06.022. [DOI] [PubMed] [Google Scholar]
- 23.Nyotowidjojo IS, Skinner K, Shah AS, et al. Thoracic versus nonthoracic MR imaging for patients with an MR nonconditional cardiac implantable electronic device. Pacing Clin Electrophysiol. 2018;41:589–596. doi: 10.1111/pace.13340. [DOI] [PubMed] [Google Scholar]
- 24.Padmanabhan D, Kella DK, Deshmukh AJ, et al. Safety of thoracic magnetic resonance imaging for patients with pacemakers and defibrillators. Heart Rhythm. 2019;16:1645–1651. doi: 10.1016/j.hrthm.2019.05.031. [DOI] [PubMed] [Google Scholar]
- 25.Do DH, Eyvazian V, Bayoneta AJ, et al. Cardiac magnetic resonance imaging using wideband sequences in patients with nonconditional cardiac implanted electronic devices. Heart Rhythm. 2018;15:218–225. doi: 10.1016/j.hrthm.2017.10.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Vuorinen AM, Paakkanen R, Karvonen J, et al. Magnetic resonance imaging safety in patients with abandoned or functioning epicardial pacing leads. Eur Radiol. 2022;32:3830–3838. doi: 10.1007/s00330-021-08469-6. [DOI] [PubMed] [Google Scholar]
- 27.Higgins JV, Sheldon SH, Watson RE, Jr, et al. “Power-on resets” in cardiac implantable electronic devices during magnetic resonance imaging. Heart Rhythm. 2015;12:540–544. doi: 10.1016/j.hrthm.2014.10.039. [DOI] [PubMed] [Google Scholar]
- 28.Boston Scientific (2019) Reference Guide Autogen EL ICD. Boston Scientific Corporation, St. Paul. Available via: https://www.bostonscientific.com/content/dam/Manuals/eu/current-rev-en/359408-065_ICD_RG_en_S.pdf. Accessed 7 Apr 2022
- 29.Martin ET, Coman JA, Shellock FG, Pulling CC, Fair R, Jenkins K. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. J Am Coll Cardiol. 2004;43:1315–1324. doi: 10.1016/j.jacc.2003.12.016. [DOI] [PubMed] [Google Scholar]
- 30.Sommer T, Naehle CP, Yang A, et al. Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5 Tesla in the presence of cardiac pacemakers in non-pacemaker-dependent patients: a prospective study with 115 examinations. Circulation. 2006;114:1285–1292. doi: 10.1161/CIRCULATIONAHA.105.597013. [DOI] [PubMed] [Google Scholar]
- 31.Sommer T, Bauer W, Fischbach K et al (2017) MR imaging in patients with cardiac pacemakers and implantable cardioverter defibrillators. Rofo 189:204–217 [DOI] [PubMed]
- 32.Roguin A, Zviman MM, Meininger GR, et al. Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe. Circulation. 2004;110:475–482. doi: 10.1161/01.CIR.0000137121.28722.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Bhuva AN, Moralee R, Brunker T et al (2021) Evidence to support magnetic resonance conditional labelling of all pacemaker and defibrillator leads in patients with cardiac implantable electronic devices. Eur Heart J. 10.1093/eurheartj/ehab350 [DOI] [PMC free article] [PubMed]
- 34.Padmanabhan D, Kella DK, Mehta R, et al. Safety of magnetic resonance imaging in patients with legacy pacemakers and defibrillators and abandoned leads. Heart Rhythm. 2018;15:228–233. doi: 10.1016/j.hrthm.2017.10.022. [DOI] [PubMed] [Google Scholar]
- 35.Schaller RD, Brunker T, Riley MP, Marchlinski FE, Nazarian S, Litt H. Magnetic resonance imaging in patients with cardiac implantable electronic devices with abandoned leads. JAMA Cardiol. 2021;6:549–556. doi: 10.1001/jamacardio.2020.7572. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Nazarian S, Reynolds MR, Ryan MP, Wolff SD, Mollenkopf SA, Turakhia MP. Utilization and likelihood of radiologic diagnostic imaging in patients with implantable cardiac defibrillators. J Magn Reson Imaging. 2016;43:115–127. doi: 10.1002/jmri.24971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Pieri C, Bhuva A, Moralee R, et al. Access to MRI for patients with cardiac pacemakers and implantable cardioverter defibrillators. Open Heart. 2021;8:e001598. doi: 10.1136/openhrt-2021-001598. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Junttila MJ, Fishman JE, Lopera GA, et al. Safety of serial MRI in patients with implantable cardioverter defibrillators. Heart. 2011;97:1852–1856. doi: 10.1136/heartjnl-2011-300153. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Klein-Wiele O, Garmer M, Busch M, et al. Cardiovascular magnetic resonance in patients with magnetic resonance conditional pacemaker systems at 1.5 T: influence of pacemaker related artifacts on image quality including first pass perfusion, aortic and mitral valve assessment, flow measurement, short tau inversion recovery and T1-weighted imaging. Int J Cardiovasc Imaging. 2017;33:383–394. doi: 10.1007/s10554-016-1012-z. [DOI] [PubMed] [Google Scholar]
- 40.Vuorinen AM, Lehtonen J, Pakarinen S, Holmström M, Kivistö S, Kaasalainen T. Cardiac magnetic resonance imaging–based screening for cardiac sarcoidosis in patients with atrioventricular block requiring temporary pacing. J Am Heart Assoc. 2022;11:e024257. doi: 10.1161/jaha.121.024257. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Ellenbogen KA, Wilkoff BL, Kay GN, Lau C-P, Auricchio A. Clinical cardiac pacing, defibrillation and resynchronization therapy. 5. Philadelphia: Elsevier; 2016. [Google Scholar]
- 42.Hargreaves BA, Worters PW, Pauly KB, Pauly JM, Koch KM, Gold GE. Metal-induced artifacts in MRI. AJR Am J Roentgenol. 2011;197:547–555. doi: 10.2214/AJR.11.7364. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Jungmann PM, Agten CA, Pfirrmann CW, Sutter R. Advances in MRI around metal. J Magn Reson Imaging. 2017;46:972–991. doi: 10.1002/jmri.25708. [DOI] [PubMed] [Google Scholar]
- 44.Schwartz SM, Pathrose A, Serhal AM, et al. Evaluation of image quality of wideband single-shot late gadolinium-enhancement MRI in patients with a cardiac implantable electronic device. J Cardiovasc Electrophysiol. 2021;32:138–147. doi: 10.1111/jce.14798. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Singh A, Chen W, Patel HN, et al. Impact of wideband late gadolinium enhancement cardiac magnetic resonance imaging on device-related artifacts in different implantable cardioverter-defibrillator types. J Magn Reson Imaging. 2021;54:1257–1265. doi: 10.1002/jmri.27608. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Hilbert S, Weber A, Nehrke K, et al. Artefact-free late gadolinium enhancement imaging in patients with implanted cardiac devices using a modified broadband sequence: current strategies and results from a real-world patient cohort. Europace. 2018;20:801–807. doi: 10.1093/europace/eux016. [DOI] [PubMed] [Google Scholar]
- 47.Hilbert S, Jahnke C, Loebe S, et al. Cardiovascular magnetic resonance imaging in patients with cardiac implantable electronic devices: a device-dependent imaging strategy for improved image quality. Eur Heart J Cardiovasc Imaging. 2018;19:1051–1061. doi: 10.1093/ehjci/jex243. [DOI] [PubMed] [Google Scholar]
- 48.Rashid S, Rapacchi S, Vaseghi M, et al. Improved late gadolinium enhancement MR imaging for patients with implanted cardiac devices. Radiology. 2014;270:269–274. doi: 10.1148/radiol.13130942. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Ibrahim E-SH, Runge M, Stojanovska J, et al. Optimized cardiac magnetic resonance imaging inversion recovery sequence for metal artifact reduction and accurate myocardial scar assessment in patients with cardiac implantable electronic devices. World J Radiol. 2018;10:100–107. doi: 10.4329/wjr.v10.i9.100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Gold MR, Shih H-T, Herre J, Breiter D, Zhang Y, Schwartz M. Comparison of defibrillation efficacy and survival associated with right versus left pectoral placement for implantable defibrillators. Am J Cardiol. 2007;100:243–246. doi: 10.1016/j.amjcard.2007.02.087. [DOI] [PubMed] [Google Scholar]
- 51.Varma N, Schaerf R, Kalbfleisch S, Pimentel R, Kroll MW, Oza A. Defibrillation thresholds with right pectoral implantable cardioverter defibrillators and impact of waveform tuning (the Tilt and Tune trial) Europace. 2017;19:1810–1817. doi: 10.1093/europace/euw306. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.